▸ Cosmetic Grade Lyophilized Peptide Powder ▸ Bulk Freeze-Dried Peptide Raw Material ▸ Custom Multi-Peptide Lyophilized Powder ▸ Lyophilized Peptide Vial Kit Private Label ▸ Cosmetic Peptide Formulation Customization ▸ Wholesale Skincare Lyophilized Peptide ▸ Lyophilization Technology for Cosmetic Peptide ▸ Exportable Cosmetic Peptide with Complete Documents ▸
Prostamax Peptide modification professional product presentation
Pharmaceutical & Therapeutic Peptides

Prostamax Peptide modification

Prostamax Peptide modification - structured B2B product information for pharmaceutical development / qualified b2b. Grade, specification, documentation and availability are confirmed per inquiry.

CAS473578-47-1Catalog No.GT-M15766Use scopePharmaceutical development / qualified B2B
Identity & Specification

Product Parameters

Catalog numberGT-M15766
CAS number473578-47-1
SequenceLys-Glu-Asp-Pro
One-letter sequenceConfirm against the current product specification
Molecular formulaC20H33N5O9
Molecular weightConfirm against the current product specification
Available purity>99.9%
AppearanceConfirm against the current product specification
Storage guidanced in special containers of 2 ml or 10ml with original analytical data and synthesis reports containing important information such as

Supply and Quality Options

Format

Lyophilized powder, bulk material, development sample or custom-filled vial, subject to technical feasibility.

Quality package

Product specification and batch COA; TDS, SDS and analytical support are confirmed by product and project.

Custom development

Purity, salt form, fill quantity, packaging, testing and scale can be reviewed for qualified B2B projects.

Shipping

Packaging and temperature controls are selected against material stability, route, season and destination requirements.

Product Overview

This catalog entry supports qualified B2B sourcing and technical evaluation. Identity data is organized for product matching; final salt form, purity, analytical methods, manufacturing grade, packaging and regulatory documentation are confirmed against the current quotation and quality agreement.

Documentation Available for Review

  • Current product specification and identity confirmation
  • Batch-specific certificate of analysis where applicable
  • Analytical documentation aligned to the agreed quality package
  • Storage, packaging and shipment guidance
  • GMP, sterile or injectable-development documentation when specifically applicable and contracted

Request Current Specification

Professional-use and regulatory notice

This B2B catalog listing does not represent a marketing authorization, approved indication or finished medicinal product. GMP status, injectable-development suitability, sterility, endotoxin limits, documentation and destination-market regulatory pathway must be confirmed for the exact project and supply agreement.